key: cord-0953509-4t06z2xl
authors: Vasquez-Bonilla, Walter O.; Orozco, Roberto; Argueta, Víctor; Sierra, Manuel; Zambrano, Lysien I.; Muñoz-Lara, Fausto; López-Molina, Dennis Salomón; Arteaga-Livias, Kovy; Grimes, Zachary; Bryce, Clare; Paniz-Mondolfi., Alberto; Rodríguez-Morales, Alfonso J.
title: A review of the main histopathological findings in the Coronavirus Disease 2019 (COVID-19)
date: 2020-08-02
journal: Hum Pathol
DOI: 10.1016/j.humpath.2020.07.023
sha: 20c01b7ff144e53abc5479ac62f0c900f88776c3
doc_id: 953509
cord_uid: 4t06z2xl

Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has been declared by the WHO as an emerging public health problem of global importance and classified as a pandemic. SARS-CoV-2 infection can result in diverse, multi-organ pathology, the most significant being in the lungs (diffuse alveolar damage in its different phases, microthrombi, bronchopneumonia, necrotizing bronchiolitis, viral pneumonia), heart (lymphocytic myocarditis), kidney (acute tubular injury), central nervous system (microthrombi, ischemic necrosis, acute hemorrhagic infarction, congestion, and vascular edema), lymph nodes (hemophagocytosis and histiocytosis), bone marrow (hemophagocytosis) and vasculature (deep vein thrombosis). An understanding of the spectrum and frequency of histologic findings in COVID-19 disease is essential for gaining a better understanding of disease pathophysiology and its ongoing impact on public health. To this end, we conducted a systematic meta-analysis of histopathologic observations to date and review the reported findings.

By late December 2019, several health care centers in Wuhan, Hubei province, China, reported on several clusters of patients presenting with pneumonia of unknown cause, which were epidemiologically linked to a wholesale seafood market. 1 In response to this outbreak, the China Center for Disease Control and Prevention (CCDC) sent a response team to accompany health authorities and conduct an epidemiological and etiological investigation. They concluded that the pneumonia was viral in origin. 1 The virus could not be contained given the high flow of travelers from Wuhan to other cities in China and elsewhere in the world. At this time, a new human pathogen with a high zoonotic capacity, known as the SARS-CoV-2 virus, was identified as the cause of Coronavirus Disease 2019 . It was declared by the WHO (World Health Organization) as an emerging public health problem of global importance and cataloged as a pandemic on March 11, 2020. 2, 3 As of July 22, 2020, there were 15 million confirmed cases and more than 617,000 deaths from COVID-19 in 215 countries. [2] [3] [4] The United States had confirmed more than 3.92 million cases and more than 142,000 deaths. In Latin America, Brazil has reported more than 2.16 million cases, being the second country worldwide in confirmed cases. The case fatality rate in COVID-19 disease ranges from 1% to 20%. 4 Given the current situation of the pandemic, we carried out a systematic review of the literature describing histopathological findings from samples received at surgical pathology laboratories and from postmortem studies.

Here, we summarize the histopathological findings of COVID-19 reported in publications currently available in the literature.

An electronic search was performed in databases such as PubMed/Medline, SciELO, Scopus, Google Scholar, and Web of Science. Search terms such as: "COVID-19 and histopathology", "COVID-19 and autopsy", "COVID-19 and Cytology", "COVID-19 and biopsies", "COVID-19

and Histology", "COVID-19 and the acute respiratory syndrome", "COVID-19 and post mortem findings". The search ended on June 1, 2020. Additionally, we reviewed other general sources of information. Studies in English, Spanish, Portuguese, and French were considered for inclusion.

The literature search yielded 16 ,932 articles using the search terms above. After a careful review by two independent researchers, 27 articles were considered for full analysis and extraction of information for this meta-analysis. These articles combined a total of 226 autopsies and 9 biopsies reported (Table 1) .

Postmortem examination in COVID-19 deaths have been performed in the following ways:

Postmortem microbiological sampling without an autopsy, limited autopsy with examination/biopsy of organs of interest, and complete autopsy. 5 According to U.S. CDC recommendations, autopsies in suspected or confirmed COVID-19 cases are practicable as long as appropriate safety precautions for infectious disease cases are implemented. However, in many countries, such measures may not be possible due to lack of adequate infrastructure and/or universal protective equipment availability for prosectors. 6 In order to lessen the risk of virus transmission between the cadaver and pathologist, organs should be examined in a way that minimizes aerosolization and fluid splash. Additionally, to avoid contamination of the surrounding environment, the autopsy should be performed in a site with appropriate biosafety conditions such as negative pressure ventilation and restricted access. 7, 8 The U.S. CDC recommends standard precautions, contact precautions, and airborne precautions with eye protection (goggles or face shield) during the autopsy. The following factors should be considered when deciding to perform an autopsy in a confirmed or suspected COVID-19 case: legal, medical jurisdiction, environmental monitoring facilities, availability of recommended personal protective equipment (PPE), family, and cultural wishes. 9 If an autopsy is performed on a suspected COVID-19 case, collection of the following postmortem specimens is recommended: postmortem swab specimens for SARS-CoV-2 testing (upper respiratory tract, nasopharyngeal, lower respiratory tract, and both lungs). Separate swabs to analyze other for respiratory pathogens; and tissues fixed in formalin, according to autopsy protocol. If an autopsy is not performed for a suspected case of COVID-19, collection of the following postmortem specimens is recommended: Nasopharyngeal swab specimen and separate swabs to test for other respiratory pathogens. If an autopsy is performed for a confirmed case of COVID-19, the following postmortem samples are recommended: Separate swab samples to analyze other respiratory pathogens, analyze other respiratory pathogens and formalin-fixed tissues, according to autopsy protocol. 10 In its laboratory biosecurity manual, the WHO classifies the intrinsic biological characteristics of infectious agents into four risk groups (RG). These range from level 1 (RG1), which includes microorganisms that are unlikely to cause human disease or in animals, up to level 4 (RG4), referring to those pathogens that cause severe illnesses and are easily transmissible from one individual to another. According to the international consensus on biosecurity, SARS-CoV-2 should be classified as a human pathogen of Risk Group 3 (RG3). 10 Laboratory biosecurity is classified into four levels (BSL-1 to BSL-4). These levels constitute a series of protections, including proper safeguards designed to protect laboratory personnel, as well as the environment and the surrounding community. The level of biosecurity required in laboratories derives from the risk characterization and is not automatically derived from the risk group to which the pathogen belongs. 10 Coronaviruses related to severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) are considered HG3 pathogens, while most of the other Coronavirinae are RG2. SARS-CoV-2 has recently been classified as an RG3 organism. Other viruses within RG3 include rabies, poliovirus, dengue virus, hepatitis B, C, D, and E viruses, and HIV 1 and 2, among others. 10 In general, performing an autopsy on a patient with suspected HG3 organisms requires four areas of attention: risk assessment, understanding of the pathology that can be found, universal standard precautions, and any standard operating procedures for specific HG3 pathogens. The effective use of universal precautions mitigates inaccurate or incomplete information used in risk assessment in individual cases. 11

The histopathological features of COVID-19 closely resemble those seen in SARS and MERS. 12 SARS, which is a type of pneumonia caused by the SARS coronavirus (SARS-CoV), is highly contagious and can affect multiple organs. The SARS outbreak in 2003 prompted extensive studies of its histopathological features, with the discovery that the disease predominantly attacks the lung and the immune system. 13 Based upon these findings, the authors conclude that COVID-19 causes a hypercoagulable state, endothelial dysfunction and an imbalance of innate and adaptive immune responses. 15 A series from Italy discussed autopsies of patients with COVID-19, focusing on lung lesions. There were 38 cases, 33 (86.84%) men and 5 (13.16%) women, with an average age of 69 years (range 32-86 years); hospitalization time from 1 to 23 days (average 6.87 days). A D-dimer level was available in 26 of 38 patients, with all having a high value (> 10 times the upper reference limit). On gross examination, the lungs were congested, with marked edema. On microscopy, the most significant findings were diffuse alveolar damage in the exudative and proliferative phases.

The fibrotic phase was rarely observed, due to the short life span of the studied patients. Fibrin thrombi of small arterial vessels (diameter <1 mm) were found in 33/38; half of them with> 25% tissue involvement and associated with high levels of D-dimer in the blood. These histopathological findings could explain the severe hypoxemia that characterizes the SARS symptoms in patients with SARS-CoV-2, in which they conclude that the data found strongly supports the hypothesis proposed by recent clinical studies, that COVID-19 is strictly related to coagulopathy and thrombosis. Additionally, detection of D-dimer values> 1μg / ml have been associated with a fatal outcome of COVID-19. For these reasons, the use of anticoagulants has recently been suggested as potentially beneficial in patients with severe COVID-19, although their efficacy and safety have not been demonstrated. Immunohistochemistry studies were performed on selected cases (CD45, CD68, CD61, TTF1, p40, Ki67) and Masson's trichrome, to better characterize the inflammatory infiltrate, epithelial cells, and fibrosis. 16 A series of 12 cases studied in Washington had a similar age range with the age range described in the autopsy series from Italy (70.4 years, range 42-84 years). The hospital stay after the onset of symptoms until death ranged from 1 to 14 days, with an average of 7 days. The macroscopic findings are also similar to those of other studies, with edematous lungs having an average weight of 1804 grams, without evidence of lung consolidation. One autopsy case had mild splenomegaly, 350 grams. In another case, dotted subarachnoid hemorrhages were observed overlying the brain. Other findings were of sinusoidal congestion in the liver (100%), hypertensive changes in the kidney (80%), and various degrees of atherosclerotic coronary artery disease (60%). Histopathological findings in the lungs consisted of diffuse alveolar damage in 75% of cases. In one case, there was lymphocytic myocarditis. Kidney findings consisted of arterionephrosclerosis. Viral particles were detected by electron microscopy in type I and II pneumocytes. 17 The kidney showed viral particles in the tubular epithelium, endothelium, and podocytes, without significant inflammation. Viral particles were also observed in the trachea and large intestine. SARS-CoV-2 RNA was detected in the heart tissue of the patient with lymphocytic myocarditis. 17 Schaller T et al., performed ten autopsies with a mean decedent age of 79 years (64-90 years), finding DAD in the lungs in the exudative and proliferative phases, and 1/10 in the fibrotic phase and mild lymphocytic myocarditis, respectively. 18 Remmelink M et al. performed 17 autopsies.

In addition to DAD in exudative phase and fibrotic phase, they observed pulmonary arterial microthrombi, acute pneumonia, and bronchopneumonia. SARS-CoV-2 was identified by IHC in the lungs in 11/17 autopsies. In the heart, there was chronic ischemic cardiomyopathy and acute myocardial infarction. In the liver, steatosis, hepatitis, and lobular lymphocytic infiltrates were identified. Cerebral hemorrhage was present in 8/17 cases. Other findings in the brain were ischemic necrosis (3/17), edema, and diffuse vascular congestion in 5/17 cases. SARS-CoV-2 RNA was detected in at least one organ of each patient (lung, heart, liver, intestine, spleen, kidney, and brain). 19 Nunes Duarte -Neto A et al., performed ultrasound-guided minimally invasive autopsies on ten cadavers, collecting tissue from different organs. In the lung samples, DAD in the exudative and proliferative phase was found, as well as foci of squamous alveolar metaplasia.

Immunohistochemical Ki-67 expression in alveolar and bronchiolar cells indicated a high rate of epithelial cell proliferation. Other findings were of fibrin thrombi in alveolar arterioles and suppurative pneumonia (Figures 3 and 4) . The extrapulmonary findings were divided into three categories: those attributed to comorbidities such as hypertension and diabetes, those attributable to shock, and findings that had an uncertain etiology, that is, secondary to SARS-CoV-2 infection. 20 Prilutskiy A et al, studied four autopsies directed to the thoracic cavity and abdomen. They found DAD in the lungs in the exudative phase. A further important finding was present in 3/4 autopsies: hemophagocytosis in hilar and mediastinal lymph nodes, spleen, liver and bone marrow. The predominant form of hemophagocytosis identified was lymphophagocytosis, and these were clinically related. 21 Some case reports have described bilateral diffuse alveolar damage, with evidence of hyaline membrane formation and pneumocyte denudation in the right lung, and pulmonary edema with hyaline membrane formation in the left lung, interstitial lymphocytic inflammatory infiltrates in both lungs and cytopathic viral changes, as well hepatic steatosis and mononuclear infiltrates in the heart 22, 23, 24 Other case reports have revealed congestive cardiomyopathy, with detection of the SARS-CoV-2 viral RNA in pharyngeal mucosa and lung tissue. 25 The first autopsy findings reported from Spain consisted of proliferative and fibrotic phases of DAD in the lungs with cytopathic changes and an interstitial inflammatory infiltrate composed of CD8 + lymphocytes with neutrophils. Thrombi were found in the medium and small blood vessels, the former showing expression of CD61 by immunohistochemistry indicating their platelet composition. 26 In a study describing the lung tissue of a 60-year-old patient with COVID-19, the gross findings were of congestion of the lung parenchyma with a hemorrhagic and necrotic appearance. On histology, the main findings were interstitial change with hyaline degeneration, fibrosis, and hemorrhagic infarction, as well as the formation of microthrombi. There was an inflammatory infiltrate consisting mainly of lymphocytes and plasma cells. Necrotizing bronchiolitis and alveolitis was present, with intracytoplasmic viral inclusions in the alveoli and multinucleated giant cells; immunohistochemistry (IHC) showed a mixed inflammatory cell population, variously immunopositive for CD3, CD4, CD8, CD20, CD79a, CD5, CD38, and CD68. 27 In patients that went for surgery due to cancer with concurrent COVID-19, the histology of the lungs showed proliferative and exudative phases of diffuse alveolar damage with accompanying edema and prominent proteinaceous and fibrinoid exudates, vascular congestion, and inflammatory cells including multinucleated giant cells. Additionally, reactive alveolar hyperplasia was observed. Fibroblastic proliferation was present, indicative of early organization. 28 Similar findings were described in a report of surgical samples in patients with lung cancer, complicated by COVID-19. Immunohistochemistry (IHC) revealed a sparse infiltration of CD3, CD20 and CD8 lymphocytes into the alveolar septum. In contrast, plasma cells and a CD68-positive macrophages predominated. 29 Pernazza A et al., in a surgical sample of a patient with a history of lung cancer, found histological findings such as pneumocyte damage, alveolar hemorrhage, and clusters of macrophages and interstitial inflammatory infiltrates; characteristics similar to those previously described in SARS-CoV-2 infection and consistent with previously postulated mechanisms underlying the lung damage seen in SARS. 30 A team from Oklahoma USA performed two complete autopsies of COVID-19 patients, the first was a 77-year-old male patient, with a six-day history of chills and intermittent fever, and a past medical history significant for hypertension, deep vein thrombosis, splenectomy, pancreatitis due to cholelithiasis, and osteoarthritis after total knee replacement. Among the critical findings, the lungs were heavy, weighing 2452 grams, firm and diffusely edematous; histologically, there was Histopathologically, the lung sections showed bilateral diffuse alveolar damage with a mild to moderate lymphocytic infiltrate, composed of a mixture of CD4 + and CD8 + lymphocytes, fibrin thrombi within small vessels, and distended capillaries. 33 Zhang H et al., describe the histopathological findings of a 72-year-old patient who underwent a lung biopsy, and reported diffuse alveolar damage in the organization phase. Immunostaining of lung sections with an antibody against the Rp3 NP protein of SARS-CoV-2 revealed prominent expression in alveolar cells, including sloughed and damaged cells within the alveolar space. 34 Yao X et al., in their study of three minimally invasive post-mortems with biopsy of lung tissue also found that COVID-19 disease mainly involved the lungs, observing diffuse alveolar damage in its different phases, as well as hyaline thrombi in blood vessels. 35 They focused their attention on the kidney pathology, since clinical observations of COVID-19 patients revealed acute kidney injury with an incidence of 0.9% to 29% between different centers. Nineteen men and seven women were included, with an average age of 69 years (range 39-87 years). Eleven out of twenty-six patients had a history of hypertension or diabetes, or both.

Histopathological findings were acute tubular injury in all patients, and acute pyelonephritis with multiple foci of bacteria and diffuse polymorphonuclear leukocyte tubular casts in 2/26 patients.

Hemosiderin granules were present in the tubular epithelium of 4/26 patients. 37 particular abnormal or injured maternal vessels, and intervillous thrombi. They conclude that these changes may reflect an inflammatory or hypercoagulable systemic state that adversely affects placental physiology. 42 Dolhnikoff M et al., have studied ten COVID-19 autopsy cases to date: five men and five women, with a mean age of 67.8 years (33 to 83 years). Overall, 7/10 decedents had comorbidities including high blood pressure, diabetes mellitus, ischemic heart disease, and chronic obstructive pulmonary disease (COPD). The average hospital stay was 5.4 days (0 to 15 days).

Histologically, the lungs showed diffuse alveolar damage in the exudative/proliferative phase and little lymphocytic infiltration. The authors also observed a variable number of fibrin thrombi in small pulmonary arterioles in areas of damaged lung parenchyma, concluding and supporting the current concept of a hypercoagulable state in critically ill patients, and also demonstrating that the frequency of pulmonary micro-thrombosis is high. 43 concept provides a basis for a better understanding of the pathophysiological importance of complement in COVID-19 and could suggest targets for a specific intervention. 45 Understanding the mechanism of viral sepsis in COVID-19 is vital for optimizing clinical care in these patients.

In summary, the organs most reported to be affected by COVID-19 to date included lung, heart, vasculature, central nervous system, hemolymphatic system and kidney. Of these, the most common histology findings are within the lungs: diffuse alveolar damage at different stages (especially the exudative stage, reported in 22 out of 27 studies), inflammatory changes (in 21 studies) and microthrombi/thrombi (in 11) (Table 1) .

Findings in other organs include the following: focal lymphocytic myocarditis within the heart, acute tubular injury in the kidney, central nervous system vascular abnormalities with microthrombi, ischemic necrosis, acute hemorrhagic infarction, congestion, and vascular edema, hemophagocytosis within the lymph nodes and bone marrow, and deep vein thrombosis within the vasculature with associated pulmonary thromboembolism.

The extent of post-mortem examination varies between the different studies, ranging from microbiological sampling without autopsy, limited examination of organs of interest, through full autopsy. Reasons for this variability have included lack of adequate infrastructure, availability of appropriate biosafety conditions and/or personal protective equipment, and attempts to minimize prosector exposure to virus.

After multiple rounds of discussion among basic science researchers, pathologists, and clinicians working on COVID-19, Li et al., have presented various hypotheses on the pathogenesis of SARS-CoV-2. 46 Hypotheses for the pathogenesis of these findings at biopsy or autopsy include disordered immune response to the virus, with a hyperinflammatory state, and abnormal coagulation which may be secondary to the immune response or related directly to viral injury of endothelial cells. Ongoing scientific research is needed to further explore SARS-CoV-2 and its impact on the human body and, by extension, global public health. 46 Since the WHO declared the COVID-19 pandemic, all health care personnel, including pathologists, have been urged in a common effort of solidarity in the different disciplines in which they work, with an emphasis on prioritization of activities at this time of global health emergency, thus maintaining a high level and optimal response time for routine diagnostic activity while concurrently investigating the COVID-19 disease process. Postmortem histopathological findings and biopsies could play an essential role in understanding the pathophysiology of SARS-CoV-2 infection. Indeed, utilizing appropriate biosafety precautions, the U.S. CDC and WHO calls for action to perform full and detailed autopsies on patients who have suffered from severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), leading to coronavirus disease 2019 (COVID-19). 47, 48 Finally, further research utilizing fresh, frozen and formalin-fixed tissues obtained from autopsy or biopsy is needed to better understand the tropism of SARS-CoV-2 and the extent of its effects on different organs and tissues. For example, the central nervous system deserves in-depth analysis to reveal the impact of the virus on the brain and correlation with neurological manifestations and complications. [49] [50] [51] Immunohistochemistry, genomic and PCR-based techniques performed on these tissues will be relevant for such investigations in the near future. 

A Novel Coronavirus from Patients with Pneumonia in China

Preparación y control de la enfermedad por coronavirus 2019 (COVID-19) en América Latina

Enfermedad por coronavirus 2019 (COVID-19) en América Latina: papel de la atención primaria en la preparación y respuesta

Pan American Health Organization / World Health Organization. Epidemiological Update: Coronavirus disease (COVID-19)

Elhunytakkal kapcsolatos teendők COVID-19-gyanús, valószínűsített és megerősített esetekben

Management of the corpse with suspect , probable or confirmed COVID-19 respiratory infection -Italian interim recommendations for personnel potentially exposed to material from corpses , including body fluids , in morgue structures and during autopsy pra

Perspectives on the death investigation during the COVID-19 pandemic

Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 (COVID-19

Biosafety in surgical pathology in the era of SARS-Cov2 pandemia. A statement of the Italian Society of Surgical Pathology and Cytology

Autopsy in suspected COVID-19 cases

Gross examination report of a COVID-19 death autopsy. Fa yi xue za zhi

Review and Prospect of Pathological Features of Corona Virus Disease. Fa yi xue za zhi

Analysis of coronavirus disease-19 (COVID-19) based on SARS

Zhonghua bing li xue za zhi = Chinese journal of pathology

Pathophysiology of SARS-CoV-2 : targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases

Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections

Postmortem Examination of Patients With COVID-19

Unspecific post-mortem findings despite multiorgan 1 viral spread in COVID-19 patients

SARS-CoV-2 Infection Associated Hemophagocytic Lymphohistiocytosis: An autopsy series with clinical and laboratory correlation

Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory medicine

Postmortem Lung Findings in an Asthmatic Patient With Coronavirus Disease

COVID-19 in a Hispanic Woman: Autopsy Report with Clinical Pathological Correlation

Evidence for systematic autopsies in COVID-19 positive deceased

La primera autopsia COVID-19 en España después del inicio de la pandemia

Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID-19)

Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

The pathological changes and related studies of novel coronavirus

Zhonghua bing li xue za zhi = Chinese journal of pathology

Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen

COVID-19 Autopsies

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. The Lancet Respiratory Medicine

Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19

Multiscale 3-dimensional pathology findings of COVID-19 diseased lung using high-resolution cleared tissue microscopy

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against

Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

SARS-CoV-2 Infection of the Placenta

Placental Pathology in COVID-19

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Enothelial cell infection and endotheliitis in COVID-19. The Lancet

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Translational research : the journal of laboratory and clinical medicine

SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet

What are the priorities of pathologists' activities during COVID-19 emergency?

A Call to Action: The Need for Autopsies to Determine the Full Extent of Organ Involvement Associated With COVID-19

Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Fatal pulmonary thromboembolism in SARS-CoV-2-infection

Coronavirus Disease 2019-COVID-19